发明名称 |
High dose levodopa capsules for pulmonary use |
摘要 |
The present invention provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L. The invention further provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L wherein the capsule's shell comprises hydroxypropylmethylcellulose (HPMC) and titanium dioxide. |
申请公布号 |
AU2013342246(A1) |
申请公布日期 |
2015.07.02 |
申请号 |
AU20130342246 |
申请日期 |
2013.11.08 |
申请人 |
CIVITAS THERAPEUTICS, INC. |
发明人 |
KEE, KEVIN D.;PENACHIO, ERNEST D.;KAMERKAR, ABHIJIT;LIPP, MICHAEL M.;BATYCKY, RICHARD P. |
分类号 |
A61K9/12;A61K31/137;A61P25/16 |
主分类号 |
A61K9/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|